Tesamorelin dosage: a complete 2026 guide

The studied dose of tesamorelin is 2 mg injected under the skin once a day, into the abdomen. That is the dose the FDA approved in 2010 for HIV-associated lipodystrophy, a condition of excess visceral fat. Newer forms, Egrifta SV and Egrifta WR, reach a similar effect at smaller measured volumes, so they are not swapped milligram for milligram. pru does not offer tesamorelin. Here is how the dosing works, what the research shows, and where the smart, proactive choice lives.

Tesamorelin dosage at a glance

The classic tesamorelin dose is 2 mg once a day, injected under the skin of the abdomen. It was approved this way for one specific medical use, not for general weight loss. Two newer formulations use different concentrations, so they are dosed by measured volume, not by the same 2 mg number.

What tesamorelin is and how it works

Tesamorelin is a lab-made copy of growth hormone-releasing hormone, or GHRH. It signals the pituitary gland to release your own growth hormone in natural pulses. That growth hormone then raises a marker called IGF-1. The studied result was a drop in visceral fat, the deep belly fat around the organs.

• It is a peptide given by daily subcutaneous injection, not a pill.
• It works on your own hormone system rather than acting like a GLP-1.
• It was studied for visceral fat, which is different from total scale weight.
• You can read the fuller science in the tesamorelin guide.

Tesamorelin dosage by formulation

Here is the key point most sources miss: the three FDA-approved tesamorelin products are not interchangeable milligram for milligram. Each vial holds a different concentration, so the daily dose is measured differently. Always match the dose to the exact product in hand.

How tesamorelin is taken and monitored

Tesamorelin is a once-daily injection into the abdomen, with the injection spot rotated to avoid skin changes. The label does not lock you to a clock time. Because your body's growth hormone naturally pulses at night, many people inject at bedtime, but the timing choice belongs to the prescribing physician.

• Inject once daily under the skin of the abdomen, rotating the site each day.
• Reconstitute exactly as the product instructions say; each form is mixed differently.
• IGF-1 is checked before and during use, because tesamorelin raises it.
• In the phase 3 program it was dosed continuously for 52 weeks with no scheduled breaks, and response held steady with no loss of effect over time.

What tesamorelin trials showed about fat

The evidence for tesamorelin is specific. In the approval trials, adults with HIV-associated fat accumulation took 2 mg daily and cut visceral fat by roughly 18% at 26 weeks, versus under 5% on placebo. Note the target: this was deep abdominal fat, not large drops in total body weight.

That distinction matters for anyone comparing peptides for body composition. If your goal is meaningful weight loss, the trial base for tesamorelin is narrow and tied to one medical condition. GLP-1 medicines were studied directly for weight, which is why pru's weight-loss offering is built on compounded semaglutide and tirzepatide instead.

Tesamorelin dosage vs GLP-1 dosing

Tesamorelin and GLP-1 medicines are different tools on different schedules. One nudges your own growth hormone daily; the other works on appetite and blood-sugar signaling once a week. Here is the side-by-side.

For the weekly GLP-1 schedule and how the dose steps up over time, see the GLP-1 weight-loss timeline.

Tesamorelin side effects at the usual dose

At the standard daily dose, most side effects reported in trials were mild and local. Injection-site reactions were the most common, followed by joint and muscle aches and some fluid retention. Raising IGF-1 is the reason blood levels are tracked during use.

• Injection-site reactions such as redness, itching, or swelling (about 1 in 4 in trials).
• Joint pain, muscle aches, or tingling in the hands.
• Fluid retention or mild swelling in the limbs.
• Rising IGF-1, which the physician monitors and uses to guide dosing.

Why research-grade tesamorelin vials are a real risk

Tesamorelin is FDA-approved only for HIV-associated lipodystrophy. Most tesamorelin sold online for fat loss or anti-aging is grey-market, labeled research-use-only or not-for-human-use. Those vials skip the checks that make a dose trustworthy.

How pru handles tesamorelin and weight loss

pru does not offer tesamorelin. We cover it so you can weigh it honestly, then point you to what a physician can actually prescribe through a legitimate pharmacy. For weight and metabolism, that means compounded GLP-1s. Getting ahead of your metabolic health is a smart, responsible move, and pru exists to make that proactive choice the accessible one: licensed physicians, pharmacy-grade medicine, and at-cost pricing on a single path. When you are ready, the next step is right here.

• A board-certified physician reviews your intake and confirms whether a compounded GLP-1 is a fit; you select, the physician confirms.
• Prescriptions are filled by FDA-regulated 503A compounding pharmacies, not research-grade suppliers.
• pru's live weight-loss options are compounded semaglutide and compounded tirzepatide, both pharmacy-grade.
• Peptides are priced at cost and itemized under a ~$50/month membership; a higher dose costs a little more in materials, never a member markup. See pricing.
• Browse the full fat loss and metabolism lineup to compare options.

Related reading

• Tesamorelin: a complete guide
• Tesamorelin vs AOD-9604
• Best peptides for weight loss
• Semaglutide vs tirzepatide
• GLP-1 weight-loss timeline
• Shop fat loss and metabolism

Common questions